Larvol Delta - Anixa-Biosciences-Announces-Timing-of-Public-Release-of-Data-from-the-Phase-1-Study-of-its-Breast-Cancer-Vaccine-at-the-39th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting

alpha-lactalbumin vaccine - Anixa Biosci, Cleveland Clinic

https://www.prnewswire.com/news-releases/anixa-biosciences-announces-timing-of-public-release-of-data-from-the-phase-1-study-of-its-breast-cancer-vaccine-at-the-39th-society-for-immunotherapy-of-cancer-sitc-annual-meeting-302297172.html

Nov 6, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next